Clinical Trial Update: Long-acting Biomedical HIV Prevention in Transgender Women [NA]

View source ↗

Summary

The clinical trial evaluating long-acting biomedical HIV prevention in transgender women has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: University of Colorado, Denver | Conditions: HIV Prevention, Transgender Women | NA | Status: TERMINATED